Wed, Nov 19, 12:30 PM, Zacks
St. Jude Medical's CardioMEMS HF System Tests Positive - Analyst Blog
St. Jude Medical (STJ) plans to pioneer an entirely new market with its innovative CardioMEMS technology and expects the same to become a major new growth driver for the company in 2015 and beyond.
Wed, Oct 15, 8:35 AM, Zacks
St. Jude Medical Beats on Q3 Earnings by a Penny - Analyst Blog
For full year 2014, St. Jude Medical (STJ) downgraded its revenues guidance to the range of $5,568 to $5,648 million compared with the earlier range of $5,640 to $5,760 million.